Tonya McLeod, MD
Dermatology · Charlotte, NCNPI 1598742603
Payments from drug & device makers
Across 226 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Galderma Laboratories, L.p.$811
- LEO Pharma Inc.$564
- Sanofi$434
- Sun Pharmaceutical Industries Inc.$310
- Merz North America, Inc.$290
- plus $1K from 19 others
What the payments were for
- Speaking & faculty fees$4509%
- Food & beverage$4,67691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 80 | $1,665 |
| Galderma Laboratories, L.p. | 16 | $811 |
| LEO Pharma Inc. | 25 | $564 |
| Sanofi | 26 | $434 |
| Sun Pharmaceutical Industries Inc. | 15 | $310 |
| Merz North America, Inc. | 7 | $290 |
| Pfizer | 16 | $284 |
| E.r. Squibb & Sons, L.L.C. | 7 | $122 |
| Novartis | 6 | $108 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $61 |
| VYNE Pharmaceuticals Inc. | 3 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Lilly USA, LLC | 3 | $50 |
| UCB, Inc. | 2 | $50 |
| Genentech USA, Inc. | 3 | $48 |
| Incyte Corporation | 2 | $39 |
| Strata Skin Sciences, Inc. | 1 | $30 |
| DUSA Pharmaceuticals, Inc. | 2 | $27 |
| Organon | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
| Biofrontera Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Dermira, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
How this compares
$5,126 in reported general payments places this provider in the 65th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $48,067 |
| Doxycycline Ir-DrDoxycycline Monohydrate | 11 | $7,056 |
| Clobetasol Propionate | 66 | $2,213 |
| Ketoconazole | 48 | $725 |
| Doxycycline Hyclate | 37 | $588 |
| Clindamycin Phosphate | 18 | $584 |
| Fluocinonide | 14 | $498 |
| Mupirocin | 58 | $362 |
| Fluticasone Propionate | 16 | $314 |
| Triamcinolone Acetonide | 46 | $308 |
| Cephalexin | 18 | $306 |
| Hydrocortisone | 29 | $141 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Charlotte
- Patrick McElgunnCharlotte$1.6M
- Deborah NixonCharlotte$906K
- Marc DarstCharlotte$829K
- Catherine PointonCharlotte$731K
- Gary SlaughterCharlotte$55K
- Rosalyn GeorgeWilmington$6.5M
- Steven FeldmanWinston Salem$4.3M
- Adnan NasirRaleigh$4.1M
- Christopher SayedChapel Hill$3.3M
- Zoe DraelosHigh Point$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.